Skip to content

Reducing radiation exposure during InterStim lead placement

Prospective randomized blinded study evaluating ultrasound versus fluoroscopy guided sacral InterStim® lead placement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37385347
Enrollment
40
Registered
2017-01-10
Start date
2015-03-04
Completion date
Unknown
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder, fecal incontinence Nervous System Diseases Overactive bladder, fecal incontinence

Interventions

Eligible participants are randomly assigned into either the fluoroscopy or ultrasound group. Randomization is performed using a computer generated randomization number which assigns each patient to ei

Sponsors

Metro Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of overactive bladder, non-obstructive urinary retention, or fecal incontinence 2. Aged 18 years or older 3. Failure of previous conservative measures (i.e. behavior modification, biofeedback, pelvic floor training, at least one antimuscarinic or beta-agonist medication) 4. Medically fit to undergo proposed surgery 5. Patient able to consent

Exclusion criteria

Exclusion criteria: 1. Pregnant or planning on becoming pregnant 2. Severe or uncontrolled diabetes with peripheral nerve involvement 3. Knowledge of planned MRI or other procedures precluding implantation of device or need for removal 4. Severe BPH, prostate cancer, urethral stricture, or other mechanical obstruction 5. Active urinary tract, skin, or soft tissue infection

Design outcomes

Primary

MeasureTime frame
Overall surgery time is measured in seconds until the end of surgery

Secondary

MeasureTime frame
1. Number of skin punctures made during the surgical procedure 2. Quality of life is assessed using the following questionnaires at baseline, 4 weeks and 2 years: 2.1. The International Consultation on Incontinence Modular Questionnaire Overactive Bladder Symptoms Quality of Life (ICIQ-OABqol) for urinary symptoms 2.2. The Overactive Bladder Symptom Score (OABSS) for urinary symptoms 2.3. The Fecal Incontinence Quality of Life Scale (FIQL) for fecal incontinence

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026